Advisor Group Holdings, Inc. Corcept Therapeutics Inc Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 16,549 shares of CORT stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,549

Previous 16,773 1.34%

Holding current value

$1.25 Million

Previous $1.23 Million 11.7%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$67.17 - $83.9 $15,046 - $18,793	-224 Reduced 1.34%	16,549 $1.38 Million
Q2 2025 Sep 04, 2025	BUY	$62.24 - $91.93 $122,114 - $180,366	1,962 Added 13.25%	16,773 $1.23 Million
Q2 2025 Aug 13, 2025	BUY	$62.24 - $91.93 $160,516 - $237,087	2,579 Added 21.08%	14,811 $1.09 Million
Q1 2025 May 12, 2025	SELL	$49.85 - $114.22 $164,255 - $376,354	-3,295 Reduced 21.22%	12,232 $1.4 Million
Q4 2024 Jun 06, 2025	BUY	$44.66 - $60.85 $35,772 - $48,740	801 Added 6.55%	13,033 $656,000

Q4 2024 Feb 07, 2025	BUY	$44.66 - $60.85 $11,477 - $15,638	257 Added 1.68%	15,527 $782,000
Q3 2024 Nov 13, 2024	SELL	$29.51 - $46.26 $750,586 - $1.18 Million	-25,435 Reduced 62.49%	15,270 $706,000
Q2 2024 Aug 13, 2024	BUY	$22.21 - $34.48 $275,537 - $427,758	12,406 Added 43.84%	40,705 $1.32 Million
Q1 2024 May 10, 2024	BUY	$21.1 - $27.46 $333,844 - $434,472	15,822 Added 126.81%	28,299 $712,000
Q4 2023 Feb 12, 2024	SELL	$24.82 - $32.88 $127,996 - $169,562	-5,157 Reduced 29.24%	12,477 $405,000
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $243,757 - $375,010	11,095 Added 169.67%	17,634 $480,000
Q2 2023 Aug 10, 2023	SELL	$21.44 - $25.15 $79,585 - $93,356	-3,712 Reduced 36.21%	6,539 $145,000
Q1 2023 May 12, 2023	BUY	$19.2 - $24.47 $63,705 - $81,191	3,318 Added 47.86%	10,251 $222,000
Q4 2022 Feb 10, 2023	BUY	$19.95 - $29.96 $27,570 - $41,404	1,382 Added 24.9%	6,933 $140,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $19,290 - $22,742	781 Added 16.37%	5,551 $142,000
Q2 2022 Aug 10, 2022	BUY	$17.33 - $25.3 $15,995 - $23,351	923 Added 23.99%	4,770 $117,000
Q1 2022 May 04, 2022	SELL	$16.53 - $25.21 $39,589 - $60,377	-2,395 Reduced 38.37%	3,847 $33,000
Q3 2021 Nov 05, 2021	SELL	$19.68 - $22.53 $1,200 - $1,374	-61 Reduced 0.97%	6,242 $124,000
Q2 2021 Aug 02, 2021	SELL	$19.97 - $24.43 $107,738 - $131,799	-5,395 Reduced 46.12%	6,303 $140,000
Q1 2021 May 13, 2021	SELL	$23.49 - $30.56 $563 - $733	-24 Reduced 0.2%	11,698 $286,000
Q4 2020 Feb 10, 2021	BUY	$16.78 - $27.3 $177,465 - $288,724	10,576 Added 922.86%	11,722 $306,000
Q3 2020 Nov 12, 2020	BUY	$12.46 - $19.98 $3,090 - $4,955	248 Added 27.62%	1,146 $19,000
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $2,530 - $4,199	-230 Reduced 20.39%	898 $15,000
Q1 2020 May 18, 2020	BUY	$10.11 - $14.04 $11,404 - $15,837	1,128 New	1,128 $14,000

Others Institutions Holding CORT

# of Institutions

479

Shares Held

80.5M

Call Options Held

596K

Put Options Held

710K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.09B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Corcept Therapeutics Inc Transaction History